prof. MUDr. Jiří Mayer, CSc.

2024

• Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia

  KUTER David J MAYER Jiří EFRAIM Merlin BOGDANOV Lachezar H BAKER Ross KAPLAN Zane GARG Mamta JANSEN A J Gerard TRNENY Marek CHOI Philip Y MCDONALD Vickie GUMULEC Jaromir KOSTAL Milan GERNSHEIMER Terry GHANIMA Waleed DAAK Ahmed COOPER Nichola

  Article in Periodical

  Blood advances, year: 2024, volume: 8, edition: 7, DOI

• Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry

  BRIOLI Annamaria LOMAIA Elza FABISCH Christian SACHA Tomasz KLAMOVA Hana MOROZOVA Elena GOLOS Aleksandra ERNST Philipp OLSSON-STROMBERG Ulla ŽÁČKOVÁ Daniela NICOLINI Franck E BAO Han CASTAGNETTI Fausto PATKOWSKA Elzbieta MAYER Jiří HIRSCHBUEHL Klaus PODGORNIK Helena PACZKOWSKA Edyta PARRY Anne ERNST Thomas VOSKANYAN Astghik SZCZEPANEK Elzbieta SAUSSELE Susanne FRANKE Georg-Nikolaus KIANI Alexander FABER Edgar KRAUSE Stefan CASADO Luis Felipe LEWANDOWSKI Krzysztof EDER Matthias ANHUT Peter GIL Justyna SUEDHOFF Thomas HEBART Holger HEIBL Sonja PFIRRMANN Markus HOCHHAUS Andreas LAUSEKER Michael

  Article in Periodical

  Leukemia, year: 2024, volume: 38, edition: 5, DOI

• MethScore as a new comprehensive DNA methylation-based value refining the prognosis in acute myeloid leukemia

  SESTAKOVA Sarka SALEK Cyril KUNDRAT David CEROVSKA Ela VYDRA Jan JEŽÍŠKOVÁ Ivana FOLTA Adam MAYER Jiří CETKOVSKY Petr REMESOVA Hana

  Article in Periodical

  CLINICAL EPIGENETICS, year: 2024, volume: 16, edition: 1, DOI

• Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study

  POTT Christiane JURINOVIC Vindi TROTMAN Judith KEHDEN Britta UNTERHALT Michael HEROLD Michael RICHARD van der Jagt JANSSENS Ann KNEBA Michael MAYER Jiří YOUNG Moya SCHMIDT Christian KNAPP Andrea NIELSEN Tina BROWN Helen SPIELEWOY Nathalie HARBRON Chris BOTTOS Alessia MUNDT Kirsten MARCUS Robert HIDDEMANN Wolfgang HOSTER Eva

  Article in Periodical

  Journal of clinical oncology, year: 2024, volume: 42, edition: 5, DOI

• MOLECULAR MECHANISM OF NON-GENETIC ADAPTATION TO BTK INHIBITOR THERAPY IN CLL

  ONDRIŠOVÁ Laura ŠEDA Václav HLAVÁČ Kryštof HOFERKOVÁ Eva PAVELKOVÁ Petra KOŠŤÁLOVÁ Lenka FILIP Daniel FARIA ZENI Pedro PANOVSKÁ Anna PLEVOVÁ Karla POSPÍŠILOVÁ Šárka SIMKOVIC M. VRBACKÝ F. LYSÁK Daniel DAVIDS MS. MARTIN-SUBERO JI. BROWN JR. DOUBEK Michael FORCONI Francesco MAYER Jiří MRÁZ Marek

  Conference abstract

  Year: 2024, type: Conference abstract

• Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes

  PERUSINI Maria Agustina ŽÁČKOVÁ Daniela KIM TaeHyung PAGNANO Katia B B PAVLOVSKY Carolina JEŽÍŠKOVÁ Ivana KVETKOVÁ Anežka JURČEK Tomáš KIM Jaeyoon John YOO Young Seok YI Seongyoon LEE Hyewon KIM Kyoung Ha CHANG Myunghee JOSE-MARIO Capo-Chichi MEDEIROS Jessie ARRUDA Andrea MINDEN Mark D ZHANG Zhaolei ABELSON Sagi MAYER Jiří KIM Dennis Dong Hwan

  Article in Periodical

  Blood advances, year: 2024, volume: 8, edition: 10, DOI

• Novel casein kinase 1 alpha inhibitors for the treatment of resistant AML and solid tumors

  JANOVSKÁ Pavlína RADASZKIEWICZ Tomasz Witold PROCHAZKOVA P PRIŠTICOVÁ Ingrid PLEŠINGEROVÁ Hana ČULEN Martin ŠMÍDA Michal BUŠA Daniel LADUNGOVÁ Adriana MAIER Lukáš HAVEL Štěpán MAYER Jiří SCHEER A PARUCH Kamil BRYJA Vítězslav

  Conference abstract

  Year: 2024, type: Conference abstract

• Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study

  GEISSLER Klaus KORISTEK Zdenek BERNAL del Castillo Teresa NOVAK Jan RODRIGUEZ-MACIAS Gabriela METZELDER Stephan K ILLES Arpad MAYER Jiří ARNAN Montserrat KEATING Mary-Margaret KRAUTER Juergen LUNGHI Monia FRACCHIOLLA Nicola Stefano PLATZBECKER Uwe SANTINI Valeria SANO Yuri OGANESIAN Aram KEER Harold LUEBBERT Michael

  Article in Periodical

  British journal of haematology, year: 2024, volume: 205, edition: 5, DOI

• Patient-reported outcomes in patients with relapsed or refractory follicular lymphoma treated with zanubrutinib plus obinutuzumab versus obinutuzumab monotherapy: results from the ROSEWOOD trial

  TROTMAN Judith ZINZANI Pier Luigi SONG Yuqin DELARUE Richard KIM Pil IVANOVA Elena KORDE Rasika MAYER Jiří DE OLIVEIRA Ana C ASSOULINE Sarit E FLOWERS Christopher R BARNES Gisoo

  Article in Periodical

  Current medical research and opinion, year: 2024, volume: 40, edition: 11, DOI

• PILOTNÍ STUDIE SLEDOVÁNÍ ZMĚN SLOŽENÍ STŘEVNÍHO MIKROBIOMU U PACIENTŮ S HEMATOLOGICKOU MALIGNITOU POMOCÍ NANOPÓROVÉHO SEKVENOVÁNÍ

  BEZDÍČEK Matěj NYKRÝNOVÁ Markéta KABUT Tomáš WEINBERGEROVÁ Barbora REINEROVÁ Zuzana MAYER Jiří LENGEROVÁ Martina

  Conference abstract

  Year: 2024, type: Conference abstract